These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22584816)

  • 1. Use of dexmedetomidine for the treatment of alcohol withdrawal syndrome in critically ill patients: a retrospective case series.
    DeMuro JP; Botros DG; Wirkowski E; Hanna AF
    J Anesth; 2012 Aug; 26(4):601-5. PubMed ID: 22584816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Addition of Dexmedetomidine as an Adjunctive Therapy to Benzodiazepine Use in Alcohol Withdrawal Syndrome: A Literature Review.
    Ferenchak TA
    J Addict Nurs; 2017; 28(4):188-195. PubMed ID: 29200045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Addition of Dexmedetomidine as an Adjunctive Therapy to Benzodiazepine Use in Alcohol Withdrawal Syndrome: A Literature Review.
    Ferenchak TA
    J Addict Nurs; 2017; 28(4):E1-E2. PubMed ID: 29200055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical outcomes in nonintubated patients with severe alcohol withdrawal syndrome treated with continuous-infusion sedatives: dexmedetomidine versus benzodiazepines.
    Crispo AL; Daley MJ; Pepin JL; Harford PH; Brown CV
    Pharmacotherapy; 2014 Sep; 34(9):910-7. PubMed ID: 24898418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine as adjunctive therapy for the treatment of alcohol withdrawal syndrome: a systematic review protocol.
    Fiore M; Torretta G; Passavanti MB; Sansone P; Pace MC; Alfieri A; Aurilio C; Simeon V; Chiodini P; Pota V
    JBI Database System Rev Implement Rep; 2019 Oct; 17(10):2159-2164. PubMed ID: 31232889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Dexmedetomidine as an Adjunct to Phenobarbital for Alcohol Withdrawal in Critically Ill Patients.
    Ware LR; Schuler BR; Goodberlet MZ; Marino KK; Lupi KE; DeGrado JR
    J Intensive Care Med; 2023 Jun; 38(6):553-561. PubMed ID: 36703284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.
    Woods AD; Giometti R; Weeks SM
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):224-52. PubMed ID: 26447017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of flumazenil for reversal of iatrogenic benzodiazepine-associated delirium toxicity during treatment of alcohol withdrawal, a retrospective review at one center.
    Moore PW; Donovan JW; Burkhart KK; Waskin JA; Hieger MA; Adkins AR; Wert Y; Haggerty DA; Rasimas JJ
    J Med Toxicol; 2014 Jun; 10(2):126-32. PubMed ID: 24619543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine as an adjuvant in the treatment of alcohol withdrawal delirium: a case report.
    Rovasalo A; Tohmo H; Aantaa R; Kettunen E; Palojoki R
    Gen Hosp Psychiatry; 2006; 28(4):362-3. PubMed ID: 16814639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patients.
    Frazee EN; Personett HA; Leung JG; Nelson S; Dierkhising RA; Bauer PR
    J Crit Care; 2014 Apr; 29(2):298-302. PubMed ID: 24360597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine for Alcohol Withdrawal Syndrome.
    Linn DD; Loeser KC
    Ann Pharmacother; 2015 Dec; 49(12):1336-42. PubMed ID: 26400008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propofol for Treatment of Refractory Alcohol Withdrawal Syndrome: A Review of the Literature.
    Brotherton AL; Hamilton EP; Kloss HG; Hammond DA
    Pharmacotherapy; 2016 Apr; 36(4):433-42. PubMed ID: 26893017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol withdrawal syndrome in critically ill patients: protocolized versus nonprotocolized management.
    Duby JJ; Berry AJ; Ghayyem P; Wilson MD; Cocanour CS
    J Trauma Acute Care Surg; 2014 Dec; 77(6):938-43. PubMed ID: 25248063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [APPLICATION OF DEXMEDETOMIDIN FOR SEDATION OF PATIENTS IN ALCOHOL WITHDRAWAL STATE IN THE ICU].
    Belka KY
    Klin Khir; 2015 Jul; (7):62-4. PubMed ID: 26591225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal.
    Wong A; Benedict NJ; Kane-Gill SL
    J Crit Care; 2015 Apr; 30(2):405-9. PubMed ID: 25433725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are dexmedetomidine and olanzapine suitable to control delirium in critically ill elderly patients? A retrospective cohort study.
    Liu S; Zhao R; Yang R; Zhao H; Ji C; Duan M; Liu J
    Biomed Pharmacother; 2021 Jul; 139():111617. PubMed ID: 33915500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Acute Alcohol Withdrawal Syndrome in Critically Ill Patients.
    Dixit D; Endicott J; Burry L; Ramos L; Yeung SY; Devabhakthuni S; Chan C; Tobia A; Bulloch MN
    Pharmacotherapy; 2016 Jul; 36(7):797-822. PubMed ID: 27196747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of dexmedetomidine for the control of agitation in critically ill traumatic brain injury patients: a descriptive study.
    Bilodeau V; Saavedra-Mitjans M; Frenette AJ; Burry L; Albert M; Bernard F; Williamson DR
    J Clin Pharm Ther; 2021 Aug; 46(4):1020-1026. PubMed ID: 33606290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexmedetomidine for the Treatment of Hyperactive Delirium Refractory to Haloperidol in Nonintubated ICU Patients: A Nonrandomized Controlled Trial.
    Carrasco G; Baeza N; Cabré L; Portillo E; Gimeno G; Manzanedo D; Calizaya M
    Crit Care Med; 2016 Jul; 44(7):1295-306. PubMed ID: 26925523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine in addition to benzodiazepine-based sedation in patients with alcohol withdrawal delirium.
    Tolonen J; Rossinen J; Alho H; Harjola VP
    Eur J Emerg Med; 2013 Dec; 20(6):425-7. PubMed ID: 23247391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.